Iron-induced liver injury

Clinics in Liver Disease

Volumn 4, Issue 2, 2000, Pages 409-429

  Bonkovsky, Herbert L ^a,b,c,d   Lambrecht, Richard W ^a  

^a Department of Medicine ^*  (United States)

^b Biochemistry   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; INTERFERON; IRON; RIBAVIRIN; TRANSFERRIN;

ALCOHOL LIVER DISEASE; ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC LIVER DISEASE; FATTY LIVER; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HEMOLYTIC ANEMIA; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CELL DAMAGE; LIVER INJURY; LIVER TOXICITY; NONHUMAN; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PROTEIN BINDING; REVIEW; VIRUS HEPATITIS;

EID: 0033926282     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70116-1     Document Type: Article

References (69)

1. M.A. Aldouri B. Wonke A.V. Hoffbrand Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine J Clin Pathol 40 1987 1353 1359
2. N. Arber F.M. Konikoff M. Moshkowitz Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases Dig Dis Sci 39 1994 2656 2659
3. B.R. Bacon R.S. Britton Hepatic injury in chronic iron overload. Role of lipid peroxidation Chem Biol Interact 70 1989 183 226
4. B.R. Bacon R. O'Neill R.S. Britton Hepatic mitochondrial energy production in rats with chronic iron overload Gastroenterology 105 1993 1134 1140
5. B.R. Bacon J.F. Healey G.M. Brittenham Hepatic microsomal function in rats with chronic dietary iron overload Gastroenterology 90 1986 1844 1853
6. B.R. Bacon L.W. Powell P.C. Adams Molecular medicine and hemochromatosis: At the crossroads Gastroenterology 116 1999 193 207
7. B.F. Banner A.L. Barton E.E. Cable A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C Mod Pathol 8 1995 232 238
8. B.F. Banner N. Karamitsios L. Smith Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C Am J Gastroenterol 93 1998 1541 1545
9. A.L. Barton B.F. Banner E.E. Cable Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy Am J Clin Pathol 103 1995 419 424
10. B.S. Blumberg E.D. Lustbader P.L. Whitford Changes in serum iron levels due to infection with hepatitis B virus Proc Natl Acad Sci USA 78 1981 3222 3224
11. H.L. Bonkovsky Disorders of iron overload Syllabus of Postgraduate Course of the American Association for the Study of Liver Diseases 1998 Armed Forces Institute of Pathology Washington DC
12. H.L. Bonkovsky Iron and the liver Am J Med Sci 301 1991 32 43
13. H.L. Bonkovsky Mechanism of iron-potentiation of hepatic uroporphyria: Studies in cultured chick embryo liver cells Hepatology 10 1989 354 364
14. H.L. Bonkovsky Porphyria cutanea tarda and hepatitis C Viral Hepatitis Reviews 4 1998 75 95
15. H.L. Bonkovsky R.W. Lambrecht Hemochromatosis, iron overload, and porphyria cutanea tarda J.C. Barton C.Q. Edwards Hemochromatosis 2000 Cambridge University Press Cambridge
16. H.L. Bonkovsky J.V. Obando Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis Current Gastroenterology Reports 1 1999 30 37
17. H.L. Bonkovsky B.F. Banner A.L. Rothman Iron and chronic viral hepatitis Hepatology 25 1997 759 768
18. H.L. Bonkovsky B.F. Banner R.W. Lambrecht Iron in liver diseases other than hemochromatosis Semin Liver Dis 16 1996 65 82
19. H. Bonkovsky J. Israel R. Fontana Iron reduction during interferon therapy of chronic hepatitis C: Initial results of a multicenter, randomized, controlled trial in previously untreated patients [abstract] Gastroenterology 116 1999 A1191
20. H.L. Bonkovsky Q. Jawaid K. Tortorelli Non-alcoholic steatohepatitis and iron: Increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis J Hepatol 31 1999 421 429
21. H.L. Bonkovsky M. Poh-Fitzpatrick N. Pimstone Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America Hepatology 27 1998 1661 1669
22. T.H. Bothwell R.W. Charlton A.G. Motulsky Hemochromatosis C.R. Scriver A.L. Beaudet W.S. Sly The Metabolic and Molecular Basis of Inherited Disease ed 7 1995 McGraw-Hill New York 2237 2269
23. T.H. Bothwell R.W. Charlton J.D. Cook Iron Metabolism in Man 1979 Blackwell Scientific Oxford
24. G.R. Buettner B.A. Jurkiewicz Catalytic metals, ascorbate and free radicals: Combinations to avoid Radiat Res 145 1996 532 541
25. R.W. Chapman M.Y. Morgan R. Bell Hepatic iron uptake in alcoholic liver disease Gastroenterology 84 1983 143 147
26. Y. Deugnier R. Moirand A.M. Joanelle HLA-H mutations in patients with iron overload and normal transferrin saturation [abstract] Hepatology 26 1997 199A
27. Y. Deugnier B. Turlin O. Loreal Iron and neoplasia J Hepatol 28 suppl 1998 21 25
28. S. DeVirgiliis G. Cornacchia G. Sanna Chronic liver disease in transfusion-dependent thalassemia: Liver iron quantitation and distribution Acta Haematol 65 1981 32 39
29. A.M. Di Bisceglie C.A. Axiotis J.H. Hoofnagle Measurements of iron status in patients with chronic hepatitis Gastroenterology 102 1992 2108 2113
30. A.M. DiBisceglie B.R. Bacon D.E. Kleiner Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C J Hepatol 21 1994 1109 1112
31. S. Fargion A. Carazzone V. Molteni Iron and response to interferon alpha in chronic hepatitis C [abstract] Hepatology 22 1995 415A
32. S. Fargion M. Mattiolo M. Sampietro Iron as risk factor for hepatocellular carcinoma [abstract] J Hepatol 28 suppl 1998 93A
33. W.A. Faubion G.J. Gores Death receptors in liver biology and pathobiology Hepatology 29 1999 1 4
34. J.N. Feder A. Gnirke W. Thomas A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
35. 2-microglobulin interaction and cell surface expression J Biol Chem 272 1997 14025 14028
36. T.-L. Fong S.H. Han N.C.-S. Tsai A pilot randomized, controlled trial of the effect of iron depletion on long-term response to α-interferon in patients with chronic hepatitis C J Hepatol 28 1998 369 374
37. D.K. George S. Goldwurm G.A. MacDonald Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311 318
38. Z. Goodman The NASH Pathology Working Group: The pathology of non-alcoholic steatohepatitis (NASH) [abstract 30] Abstracts for Symposium on Non-Alcoholic Steatohepatitis 1998 National Institutes of Health Bethesda
39. C.N. Gross A. Irrinki J.N. Feder Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation J Biol Chem 273 1998 22068 22074
40. H. Gunshin B. Mackenzie U.V. Berger Cloning and characterization of a mammalian proton-coupled metal-ion transporter Nature 388 1997 482 488
41. H.W. Hann C.Y. Kim W.T. London Increased serum ferritin in chronic liver disease: A risk factor for primary hepatocellular carcinoma Int J Cancer 43 1989 376 379
42. H. Hayashi T. Takikawa N. Nishimura Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron Am J Gastroenterol 89 1994 986 988
43. Y. Ikura H. Morimoto H. Johmura Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C Am J Gastroenterol 91 1996 1367 1373
44. O.F. James C.P. Day Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance J Hepatol 29 1998 495 501
45. R. Kaserbacher T. Propst A. Propst Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis Hepatology 18 1993 707 708
46. R.D. Klausner T.A. Rouault J.B. Harford Regulating the fate of mRNA: The control of cellular iron metabolism Cell 72 1993 19 28
47. J. Ludwig E. Hashimoto M.K. Porayko Hemosiderosis in cirrhosis: A study of 447 native livers Gastroenterology 112 1997 882 888
48. I.T. Mak W.B. Weglicki Characterization of iron-mediated peroxidative injury in isolated hepatic lysosomes J Clin Invest 75 1985 58 63
49. McKie AT, Weher K, Brennan K, et al: A novel IRE containing mRNA predominantly expressed in duodenum and placenta encodes a basolateral membrane protein associated with iron transport. In Final Program Abstract Book of World Congress on Iron Metabolism. Sorrento Italy, Bioiron '99, 1999, p 33
50. R. Moirand A.M. Mortaji O. Loreal A new syndrome of liver iron overload with normal transferrin saturation Lancet 349 1997 95 97
51. E. Olaso S.L. Friedman Molecular regulation of hepatic fibrogenesis J Hepatol 29 1998 836 847
52. S. Parkkila A. Waheed R.S. Britton Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis Proc Natl Acad Sci U S A 94 1997 13198 13202
53. T. Patel L.R. Roberts B.A. Jones Dysregulation of apoptosis as a mechanism of liver disease: An overview Semin Liver Dis 18 1998 105 114
54. T.A. Peters C.A. Seymour Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload Clin Sci Mol Med 50 1976 75 78
55. 1-antitrypsin deficiency and genetic hemochromatosis Hepatology 16 1992 145 148
56. O. Reichard G. Norkrans A. Fryden Randomized, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin of chronic hepatitis C Lancet 351 1998 83 87
57. T.A. Rouault R.D. Klausner Iron-sulfur clusters as biosensors of oxidants and iron Trends in Biochemical Sciences 21 1996 174 177
58. S. Schalm B.E. Hansen L. Chemello Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C J Hepatol 26 1997 961 966
59. C.A. Seymour T.J. Peters Organelle pathology in primary and secondary hemochromatosis Br J Haematol 40 1979 239 253
60. P.R. Shepherd M.A. Soos K. Siddle Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes Biochem Biophys Res Commun 211 1995 535 539
61. P.R. Sinclair N. Gorman S.I. Shedlofsky Ascorbic acid deficiency in porphyria cutanea tarda J Lab Clin Med 130 1997 197 201
62. P.R. Sinclair N. Gorman J.F. Sinclair Ascorbic acid inhibits chemically-induced uroporphyria in ascorbate-requiring rats Hepatology 22 1995 565 572
63. P. Stal I. Johansson M. Ingelman-Sundberg Hepatotoxicity induced by iron overload and alcohol J Hepatol 25 1996 538 546
64. A.S. Tavill Hemochromatosis L. Schiff E.R. Scheff Diseases of the Liver ed 7 1993 Lippincott Philadelphia 669 691
65. H. Tsukamoto W. Horne S. Kamimura Experimental liver cirrhosis caused by alcohol and iron J Clin Invest 96 1995 620 630
66. D.H. VanThiel L. Friedlander P.J. Molloy Retreatment of hepatitis C interferon nonresponders with larger doses of interferon with and without phlebotomy Hepatogastroenterology 43 1996 1557 1561
67. I.R. Wanless J.S. Lentz Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
68. P. Wardman L.P. Candeias Fenton chemistry: An introduction Radiat Res 145 1996 523 531
69. X.Y. Zhou S. Tomatsu R.E. Fleming HFE gene knockout produces mouse model of hereditary hemochromatosis Proc Natl Acad Sci U S A 95 1998 2492 2497